Healius (ASX:HLS) to launch $100m share buyback

Company News

by Lauren Evans

Healius’ (ASX:HLS) board has approved an on-market share buyback of up to $100 million over the next 12 months.

The healthcare company said the buy-back will be managed within the ‘10/12 limit’ permitted by the Corporations Act, and therefore does not require shareholder approval.

Healius intends to conduct the buyback having regard to the prevailing share price, market conditions and any incremental capital requirements.

Shares in Healius (ASX:HLS) are trading 3.3 per cent higher at $4.45. 
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.